Details of second dose incidents of VITT following AZ vaccine
Dear Medicines and Healthcare products Regulatory Agency,
Please share details of the so far reported six incidents of VITT following second dose of Astra Zeneca's Covid-19 vaccine, including:
- Degree to which symptoms matched typical VITT cases following first dose
- Age of patients (or decade of age if required for patient confidentiality)
- Time of onset following second vaccination
- Any pre-existing auto-immune conditions or blood clotting disorders suffered by the patients
- Fatality rate
Yours faithfully,
Z. Dare
Thank you for your email. This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible.
Please note that we may not respond if your query:
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only
Medicines and Healthcare products Regulatory Agency
10 South Colonnade,
Canary Wharf,
London
E14 4PU
gov.uk/mhra
Stay connected
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC.
The UK has left the EU, and the transition period ends on 31 December
2020. Our [1]guidance and information can be accessed here.
References
Visible links
1. https://www.gov.uk/government/collection...
Our Ref: FOI 21/496
Dear Z. Dare,
RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000
Thank you for your enquiry which we received on 8^th May 2021.
I confirm that your request is now being handled under the Freedom of
Information Act and you should receive a reply within 20 working days from
our date of receipt.
If you need to contact us again about this request, please quote the
reference number above.
Please be aware that we publish FOIs replies and these are redacted and
are located on our website at the following link below.
[1]https://www.gov.uk/government/collection...
Kind Regards,
MHRA Customer Service Centre
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 0203 080 6000
Dear Z Dare,
Please find attached the response to your FOI request.
Kind regards,
FOI Team
Vigilance and Risk Management of Medicines Division
Medicines and Healthcare Products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now